Requiring a pharmaceutical manufacturing company to disclose to the Board of Pharmacy specified marketing information on or before January 1 of each year; requiring the Board to provide the Office of the Attorney General with access to the disclosed information; requiring the Office to report annually on the disclosures; requiring an individual to register with the Board, pay a fee, and certify adherence to a specified code of ethics before practicing pharmaceutical marketing in the State; etc.

---

Sponsored by:

Delegate Charles R. Boutin, District 34A

Delegate Carmen Amedori, District 5A

Delegate Eric M. Bromwell, District 8

Delegate Marilyn R. Goldwater, District 16

Delegate Patrick N. Hogan, District 3A

Delegate Susan K. McComas, District 35B

Delegate Nathaniel T. Oaks, District 41

Delegate Michael D. Smigiel, Sr., District 36

Delegate Frank S. Turner, District 13

Delegate Richard B. Weldon, Jr., District 3B

Bill indexed under the following Subjects:

ATTORNEY GENERAL

CIVIL ACTIONS -see also- SMALL CLAIMS

COMMITTEES AND COMMISSIONS -see also- POLITICAL COMMITTEES

COMPTROLLER

DISCLOSURE

DRUGS -see also- CONTROLLED DANGEROUS SUB; SUBSTANCE ABUSE

ETHICS

FEES -see also- DEVELOPMENT FEES AND TAXES

GIFTS

INDUSTRY AND TECHNOLOGY

PENALTIES

PHARMACISTS AND PHARMACIES

PRIVACY

REGISTRATION -see also- MOTOR VEHICLE REGISTRATION

REPORTS

RULES AND REGULATIONS

TRADE SECRETS

Bill affects the following Statutes:

Health Occupations

( 12-6B-01 , 12-6B-02 , 12-6B-03 , 12-6B-04 , 12-6B-05 , 12-6B-06 )

Documents:

Bill Text: First Reading (RTF / PDF), Third Reading, Enrolled

Fiscal Note: Available (WORD / PDF)

Amendments: None offered